If were able to get any momentum to grow, and we get enough coverage, and we get enough customers, then hopefully, at some point in the future, theyll be able to say to the PBMs, We dont need you. Cuban and Oshmyansky have even added some middlemen of their own to the companys supply chain, albeit very selectively: Theyve partnered with several smaller transparently minded and innovative PBMs, allowing employers under their plans to offer Cost Plus Drugs medications to covered employees
CagriSema's position: Solid efficacy (~23%), but the REDEFINE 4 miss against tirzepatide was a setback
GHK-Cu has gained attention for its potential in anti-aging and regenerative medicine due to its ability to promote collagen production, improve skin elasticity, and reduce inflammation
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines
Signs of degradation can include cloudiness, visible particles, or a significant change in color (e.g., from light blue to dark blue or green)